NCT00033085

Ondansetron for the Treatment of Cocaine Dependence - 1

Double-Blind, Placebo-Controlled Trial of Ondansetron for the Treatment of Cocaine Dependence

• Status: Completed
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 60 (planned)
• Sponsor: National Institute on Drug Abuse (NIDA) · NIH
• Sex: All
• Age: 18 Years – 99 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to assess the efficacy and safety of ondansetron to reduce cocaine use in subjects with cocaine dependence.

Detailed description

Double-blind, placebo-controlled, 4-parallel group design to assess the efficacy and safety of 3 wide range doses of ondansetron to reduce cocaine use in subjects with cocaine dependence and to determine the optimal dose of ondansetron.

Conditions

• Cocaine-Related Disorders
• Drug Administration Schedule

Interventions

Type	Name	Description
DRUG	Ondansetron

Timeline

• Start date: 2001-05-01
• Completion: 2002-12-01
• First posted: 2002-04-08
• Last updated: 2017-01-12

Locations

1 site across 1 country: United States